109 related articles for article (PubMed ID: 32742925)
1. Coordinated AR and microRNA regulation in prostate cancer.
Eringyte I; Zamarbide Losada JN; Powell SM; Bevan CL; Fletcher CE
Asian J Urol; 2020 Jul; 7(3):233-250. PubMed ID: 32742925
[TBL] [Abstract][Full Text] [Related]
2. Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers.
Fletcher CE; Dart DA; Bevan CL
Endocr Relat Cancer; 2014 Oct; 21(5):R409-29. PubMed ID: 25062737
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor co-regulation in prostate cancer.
Senapati D; Kumari S; Heemers HV
Asian J Urol; 2020 Jul; 7(3):219-232. PubMed ID: 32742924
[TBL] [Abstract][Full Text] [Related]
4. Androgen action in the prostate gland.
Yadav N; Heemers HV
Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
[TBL] [Abstract][Full Text] [Related]
5. TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.
Siu MK; Chen WY; Tsai HY; Chen HY; Yin JJ; Chen CL; Tsai YC; Liu YN
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):172-178. PubMed ID: 28220803
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
Shafi AA; Yen AE; Weigel NL
Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
[TBL] [Abstract][Full Text] [Related]
7. Androgen Receptor-Related Non-coding RNAs in Prostate Cancer.
Yang Y; Liu KY; Liu Q; Cao Q
Front Cell Dev Biol; 2021; 9():660853. PubMed ID: 33869227
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor and miR-206 regulation in prostate cancer.
Chua FY; Adams BD
Transcription; 2017; 8(5):313-327. PubMed ID: 28598253
[TBL] [Abstract][Full Text] [Related]
9. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
11. Targeting of Androgen Receptor Expression by Andro-miRs as Novel Adjunctive Therapeutics in Prostate Cancer.
Ebron JS; Weyman CM; Shukla GC
J Cancer Ther; 2013 Apr; 4(4A):47-58. PubMed ID: 26877888
[TBL] [Abstract][Full Text] [Related]
12. The Role of Androgen Receptor in Cross Talk Between Stromal Cells and Prostate Cancer Epithelial Cells.
Tang Q; Cheng B; Dai R; Wang R
Front Cell Dev Biol; 2021; 9():729498. PubMed ID: 34692685
[TBL] [Abstract][Full Text] [Related]
13. Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism.
Shih JW; Wang LY; Hung CL; Kung HJ; Hsieh CL
Int J Mol Sci; 2015 Dec; 16(12):28943-78. PubMed ID: 26690121
[TBL] [Abstract][Full Text] [Related]
14. Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: A review.
Anantharaman A; Friedlander TW
Urol Oncol; 2016 Aug; 34(8):356-67. PubMed ID: 26706121
[TBL] [Abstract][Full Text] [Related]
15. Regulation of protein kinase C-related kinase (PRK) signalling by the TPα and TPβ isoforms of the human thromboxane A
O'Sullivan AG; Mulvaney EP; Kinsella BT
Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):838-856. PubMed ID: 28108419
[TBL] [Abstract][Full Text] [Related]
16. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
17. Interplay between the androgen receptor signaling axis and microRNAs in prostate cancer.
Fernandes RC; Hickey TE; Tilley WD; Selth LA
Endocr Relat Cancer; 2019 May; 26(5):R237-R257. PubMed ID: 30817318
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor cofactors in prostate cancer: potential therapeutic targets of castration-resistant prostate cancer.
Shiota M; Yokomizo A; Fujimoto N; Naito S
Curr Cancer Drug Targets; 2011 Sep; 11(7):870-81. PubMed ID: 21762076
[TBL] [Abstract][Full Text] [Related]
19. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer.
Yang Y; Jia D; Kim H; Abd Elmageed ZY; Datta A; Davis R; Srivastav S; Moroz K; Crawford BE; Moparty K; Thomas R; Hudson RS; Ambs S; Abdel-Mageed AB
Clin Cancer Res; 2016 Apr; 22(7):1744-56. PubMed ID: 26553749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
